Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AIM ImmunoTech Inc.AIM · Entity 8131 | Director | April 21, 2025 | April 23, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AIM ImmunoTech Inc.
Report date April 21, 2025 · Filed April 23, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 521,723 |
Reported balance
After 2025-04-11 transaction · row 1
1 source rowRow 1 · 2025-04-11 · Purchase · Acquired 196,851 · Balance 521,723 F1: Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025. |
| Common StockSEC Table I · non-derivative | Indirectby Spouse | 190 |
Reported balance
Holding disclosure · report date 2025-04-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 190 |
| Common StockSEC Table I · non-derivative | Indirectby Trusts | 190 |
Reported balance
Holding disclosure · report date 2025-04-21 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 190 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 11, 2025 Filed Apr 23, 2025 20:35 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | PurchaseCommon Stock | 196,851 | $0.03 | $5,000.02 |
DisclosureSEC source: 0001641172-25-005862 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 521,723 F1 · date: Shares purchased pursuant to a purchase agreement executed on April 11, 2025, but first required approval from the NYSE American which was received on April 21, 2025. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:11 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 44,899 | $0.12 | $5,208.28 |
DisclosureSEC source: 0001493152-25-010821 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 324,872 F1 · balance_after: These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 19:17 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 38,580 | $0.14 | $5,208.30 |
DisclosureSEC source: 0001493152-25-009015 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,973 F1 · balance_after: These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:20 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 43,330 | $0.12 | $5,208.27 |
DisclosureSEC source: 0001493152-25-007579 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,393 F1 · balance_after: These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 21:52 UTC Amendment | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 43,330 | $0.12 | $5,208.27 |
DisclosureSEC source: 0001493152-25-007740 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,393 F2 · shares: This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed F1 · balance_after: These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 25,797 | $0.20 | $5,208.41 |
DisclosureSEC source: 0001493152-25-004671 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,063 F1 · balance_after: These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| January 31, 2025 Filed Feb 20, 2025 21:52 UTC Amendment | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 25,797 | $0.20 | $5,208.41 |
DisclosureSEC source: 0001493152-25-007739 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,063 F2 · shares: This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed F1 · balance_after: These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:05 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 27,412 | $0.19 | $5,208.28 |
DisclosureSEC source: 0001493152-25-002754 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,226 F1 · balance_after: These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| January 15, 2025 Filed Feb 20, 2025 21:52 UTC Amendment | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 27,412 | $0.19 | $5,208.28 |
DisclosureSEC source: 0001493152-25-007738 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,266 F2 · shares: This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed F1 · balance_after: These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:35 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 26,305 | $0.20 | $5,208.39 |
DisclosureSEC source: 0001493152-25-000268 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,854 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:30 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | SaleCommon Stock | 4,580 | $0.19 | $883.94 |
DisclosureSEC source: 0001493152-24-051073 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,549 Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 22:00 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 24,452 | $0.21 | $5,208.28 |
DisclosureSEC source: 0001493152-24-050437 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,803 F1 · balance_after: The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 23:36 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantCommon Stock | 22,645 | $0.23 | $5,208.35 |
DisclosureSEC source: 0001493152-24-048539 · ownership.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,351 F1 · balance_after: These shares are issue in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:50 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 50,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001493152-22-034328 · ownership.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-11-30 F1 · security: Annual Independent Director Compensation. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 15:15 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 50,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001702626-22-000004 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-03-03 Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:11 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 50,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001450324-21-000006 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-11-11 Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 19:41 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | GrantOptions · Derivative | 50,000 | $0.00 Strike: $2.77 | $0.00 |
DisclosureSEC source: 0001191434-20-000001 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-08-12 Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 18:15 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 8,358 | $0.45 | $3,801.22 |
DisclosureSEC source: 0001191434-19-000020 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,407 F1 · kind: Shares issued for 50 percent of Director's fee for the first half of December, 2019. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 17:43 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 9,503 | $0.40 | $3,801.20 |
DisclosureSEC source: 0001450324-19-000026 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,049 F1 · kind: Shares issued for 50 percent of Director's Fee for the second half of November, 2019. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 21:11 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 8,264 | $0.46 | $3,801.44 |
DisclosureSEC source: 0001450324-19-000021 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,546 F1 · kind: Shares issued for 50 percent of Director's Fee for the first half of November, 2019. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 14:48 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 7,603 | $0.50 | $3,801.50 |
DisclosureSEC source: 0001191434-19-000018 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,282 F1 · kind: Shares issued for 50 percent of Director's Fee for the second half of October, 2019. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 16:27 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 5,002 | $0.76 | $3,801.52 |
DisclosureSEC source: 0001191434-19-000016 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,768 F1 · kind: Shares issued for 50 percent of Director's fee for the second half of September, 2019. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 17:39 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 2,033 | $1.87 | $3,801.71 |
DisclosureSEC source: 0001191434-19-000014 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,766 F1 · kind: Shares issued for 50 percent of Director's fee for the first half of September, 2019. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 17:22 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 2,112 | $1.80 | $3,801.60 |
DisclosureSEC source: 0001191434-19-000012 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,733 F1 · kind: Shares issued for 50 percent of Director's fee for the second half of August, 2019. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 14:56 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 2,001 | $1.90 | $3,801.90 |
DisclosureSEC source: 0001191434-19-000010 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,621 F1 · kind: Shares issued for 50 percent of Director's fee for the first half of August, 2019. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 16:45 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 1,618 | $2.35 | $3,802.30 |
DisclosureSEC source: 0001702626-19-000008 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,620 F1 · kind: Shares issued for 50 percent of Director's fee for the second half of July, 2019. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 16:29 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 920 | $4.13 | $3,799.60 |
DisclosureSEC source: 0001191434-19-000008 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,624 F1 · kind: Shares issued for 50 percent of Director's Fee for the first half of July, 2019. Read SEC document |
| July 03, 2019 Filed Jul 8, 2019 17:50 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 866 | $4.39 | $3,801.74 |
DisclosureSEC source: 0001191434-19-000006 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,704 F1 · kind: Shares issued for 50 percent of Director's Fee for the second half of June, 2019. Read SEC document |
| June 21, 2019 Filed Jun 24, 2019 20:14 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | PurchaseCommon Stock | 9,677 | $4.03 | $38,998.31 |
DisclosureSEC source: 0001191434-19-000004 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,838 Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 17:08 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 711 | $5.35 | $3,803.85 |
DisclosureSEC source: 0001191434-19-000002 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,161 F1 · kind: Shares issued for 50 percent of Director's Fee for the first half of June, 2019. F2 · balance_after: Previous balance of the amount of securities owned was divided by 44 due to the 44/1 stock split which occurred on June 11, 2019. Read SEC document |
| June 03, 2019 Filed Jun 14, 2019 18:42 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 38,013 | $0.10 | $3,801.30 |
DisclosureSEC source: 0001702626-19-000002 · primary_doc.xml · nonDerivative · entry 4 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,805 F4 · kind: Shares issued for 50 percent of Director's Fee for the second half of May, 2019. Read SEC document |
| May 16, 2019 Filed Jun 14, 2019 18:42 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 25,342 | $0.15 | $3,801.30 |
DisclosureSEC source: 0001702626-19-000002 · primary_doc.xml · nonDerivative · entry 3 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,792 F3 · kind: Shares issued for 50 percent of Director's Fee for the first half of May, 2019. Read SEC document |
| May 09, 2019 Filed Jun 18, 2019 14:58 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | ConversionCommon Stock | 140,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001191434-19-000001 · primary_doc.xml · nonDerivative · entry 2 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Rights offering warrants using the cashless conversion feature, were converted into .70 number of shares. Read SEC document |
| May 06, 2019 Filed Jun 14, 2019 18:42 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 18,101 | $0.21 | $3,801.21 |
DisclosureSEC source: 0001702626-19-000002 · primary_doc.xml · nonDerivative · entry 2 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,450 F2 · kind: Shares issued for 50 percent of Director's Fee for the second half of April, 2019. Read SEC document |
| May 03, 2019 Filed Jun 14, 2019 18:42 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherCommon Stock | 27,152 | $0.14 | $3,801.28 |
DisclosureSEC source: 0001702626-19-000002 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,349 F1 · kind: Shares issued for 50 percent of Director's Fee for the first half of April, 2019. Read SEC document |
| March 18, 2019 Filed Jun 18, 2019 14:58 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | ConversionCommon Stock | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001191434-19-000001 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share has a stated value of $1,000 and was converted into 5,000 shares of Series B Common Stock for each of the forty shares issued. Read SEC document |
| March 04, 2019 Filed Mar 13, 2019 18:55 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherSubr Rights(to buy) · Derivative | 40 | $1,000.00 Strike: $1,000.00 | $40,000.00 |
DisclosureSEC source: 0001583701-19-000005 · primary_doc.xml · derivative · entry 3 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Pref Stk/Warrants · Not disclosed shares Expires 2019-03-05 F1 · derivative.underlying: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F2 · derivative.underlying: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F3 · derivative.underlying_shares: Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants. Read SEC document |
| March 04, 2019 Filed Mar 13, 2019 18:55 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherWarrants | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001583701-19-000005 · primary_doc.xml · nonDerivative · entry 2 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 F2 · security: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F2 · shares: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F2 · price: Each warrant is exercisable for one share of common stock at an exercise price of $0.20 per share and was issued as part of a subscription right issued in a rights offering. F3 · price: Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants. Read SEC document |
| March 04, 2019 Filed Mar 13, 2019 18:55 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | OtherSeries B Convertible Preferred Stock | 40 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001583701-19-000005 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40 F1 · security: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F1 · shares: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F1 · price: Each share has a stated value of $1,000 and is convertible into 5,000 shares of common stock and was issued as part of a subscription right issued in a rights offering. F3 · price: Represents $1,000 per unit purchased in the rights offering, each unit consisting of 1 shares of Series B Preferred Stock and 5,000 warrants. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 17:12 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 50,000 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001450324-19-000006 · primary_doc.xml · derivative · entry 2 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-01-28 F2 · security: This option is being issued to senior management for serving as Chair on committees in the year 2019. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 17:12 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 207,343 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001450324-19-000006 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,343 Underlying: Common Stock · 207,343 shares Expires 2029-01-28 F1 · security: This option is being issued to senior management for a voluntary 100% deferral of Director's fees. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 17:16 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001613377-18-000039 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,197 F1 · kind: The Board of Directors awarded 2,500 shares of Company common stock to each employee, executive, and board member as a holiday bonus to be issued after January 2, 2019. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 17:00 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 172,786 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001613377-18-000026 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,786 Underlying: Common Stock · 172,786 shares Expires 2028-10-17 F1 · security: This option is being issued to senior management for a voluntary 100% deferral of Director's fees. Read SEC document |
| October 17, 2018 Filed Oct 17, 2019 21:06 UTC | AIM ImmunoTech Inc. AIM · Entity 8131 | OtherCommon Stock | 6,911 | $0.55 | $3,801.05 |
DisclosureSEC source: 0001450324-19-000016 · primary_doc.xml · nonDerivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,679 F1 · kind: Shares issued for 50 percent of Director's Fee for the first half of October, 2019. Read SEC document |
| July 18, 2018 Filed Jul 20, 2018 14:11 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 98,098 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001613377-18-000015 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,098 Underlying: Common Stock · 98,098 shares Expires 2028-07-18 F1 · security: This option is being issued to senior management for a voluntary 100% deferral of Directors fees. Read SEC document |
| May 16, 2018 Filed May 18, 2018 16:15 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 100,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001613377-18-000011 · primary_doc.xml · derivative · entry 2 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-05-16 F2 · security: This option was awarded by the Board of Directors for serving as chairman of various committees. Read SEC document |
| May 16, 2018 Filed May 18, 2018 16:15 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 152,053 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001613377-18-000011 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,053 Underlying: Common Stock · 152,053 shares Expires 2028-05-16 F1 · security: This option is being issued to senior management for a voluntary 100% deferral of Directors fees. Read SEC document |
| April 12, 2018 Filed Apr 19, 2018 19:34 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 100,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001465652-18-000008 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-04-12 F1 · security: This option is being awarded by the Board of Directors. Read SEC document |
| February 13, 2018 Filed Mar 1, 2018 19:54 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 226,023 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001191434-18-000001 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,023 Underlying: Common Stock · 226,023 shares Expires 2028-02-13 F1 · security: This option is being issued by senior management in exchange for a voluntary 100% deferral in directors fees. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 17:50 UTC | AIM ImmunoTech Inc. HEB · Entity 8131 | GrantOptions to buy Common Stock · Derivative | 29,757 | $0.26 Strike: $0.36 | $7,736.82 |
DisclosureSEC source: 0001613377-17-000042 · primary_doc.xml · derivative · entry 1 MITCHELL WILLIAM M · CIK 0001191434 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,757 Underlying: Common Stock · 29,757 shares Expires 2027-08-31 F1 · security: This option is being issued in exchange for a voluntary 100% reduction in Director's fees. F1 · price: This option is being issued in exchange for a voluntary 100% reduction in Director's fees. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.